Horizon Pharma to Host an Investment Community Briefing on

Horizon Pharma to Host an Investment Community Briefing on RAYOS(R)
on Monday, November 12, 2012 
Live Webcast to Begin at 6:30 a.m. EST 
DEERFIELD, IL -- (Marketwire) -- 10/29/12 --  Horizon Pharma, Inc.
(NASDAQ: HZNP) announced today that it will host a live webcast to
discuss the approval and initial launch of RAYOS(R) on Monday,
November 12, 2012 at 6:30 a.m. Eastern Time. The webcast will be
hosted by Timothy P. Walbert, chairman, president and chief executive
officer of Horizon Pharma and will feature presentations from leading
rheumatologists Maurizio Cutolo, M.D., of the University of Genova,
Frank Buttgereit, M.D., of the Charite at the University of Berlin,
and Arthur Weaver, M.D., of the University of Nebraska. The live
webcast and a replay may be accessed by visiting Horizon's website at
http://ir.horizon-pharma.com.  
About Horizon Pharma
 Horizon Pharma, Inc. is a biopharmaceutical
company that is developing and commercializing innovative medicines
to target unmet therapeutic needs in arthritis, pain and inflammatory
diseases. For more information, please visit www.horizonpharma.com. 
Contacts:
Robert J. De Vaere
Executive Vice President and Chief Financial Officer
investor-relations@horizonpharma.com 
Investors
Kathy Galante
Burns McClellan, Inc.
212-213-0006
kgalante@burnsmc.com 
 
 
Press spacebar to pause and continue. Press esc to stop.